We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · November 15, 2021

Association Between TNF Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19

JAMA Network Open

 

Additional Info

JAMA Network Open
Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19
JAMA Netw Open 2021 Oct 01;4(10)e2129639, Z Izadi, EJ Brenner, SK Mahil, N Dand, ZZN Yiu, M Yates, RC Ungaro, X Zhang, M Agrawal, JF Colombel, MA Gianfrancesco, KL Hyrich, A Strangfeld, L Carmona, EF Mateus, S Lawson-Tovey, E Klingberg, G Cuomo, M Caprioli, AR Cruz-Machado, AC Mazeda Pereira, R Hasseli, A Pfeil, HM Lorenz, BF Hoyer, L Trupin, S Rush, P Katz, G Schmajuk, L Jacobsohn, AM Seet, S Al Emadi, L Wise, EL Gilbert, A Duarte-García, MO Valenzuela-Almada, CA Isnardi, R Quintana, ER Soriano, TY Hsu, KM D'Silva, JA Sparks, NJ Patel, RM Xavier, CDL Marques, AM Kakehasi, RM Flipo, P Claudepierre, A Cantagrel, P Goupille, ZS Wallace, S Bhana, W Costello, R Grainger, JS Hausmann, JW Liew, E Sirotich, P Sufka, PC Robinson, PM Machado, CEM Griffiths, JN Barker, CH Smith, J Yazdany, MD Kappelman

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading